Biotech in Big Breakout..Now What To Do?

Introduction Biotechnology has been a difficult space to deploy capital over the previous ~18-24 months. This cohort plummeted over and over again from both sides of the political isle as the 2016 presidential race unfolded. Between Hillary Clinton, Bernie Sanders and Donald Trump taking aim at drug pricing via speeches, Twitter, and other social media … Continued

Read More

If you’d bought $1,000 of Bitcoin in 2010, you’d be worth $35M

The price of Bitcoin, the most popular digital crytpo-currency, has skyrocketed this year. According to Coindesk, bitcoins are currently trading for $2,483 per coin. The price is an all-time record, and the remarkable valuation blows earlier price spikes out of the water. Bitcoins have more than doubled since the beginning of 2017, when they hovered around $1,000 per coin. … Continued

Read More

Pfizer Nears Agreement to Buy Medivation

Pfizer Inc (PFE.N) is in advanced talks to acquire U.S. cancer drug company Medivation Inc (MDVN.O) for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday. Pfizer has agreed to pay a little more than $80 per share for Medivation, one of the people … Continued

Read More